BIODESIX INC — Director's Dealing 2022

Apr 11, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2022-04-07

Reporting Person: Strobeck Matthew (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-04-07	Common Stock	P	558659	$1.79	Acquired	1545586	Direct
2022-04-07	Common Stock	P	558659	$1.79	Acquired	769859	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	19933	Indirect
Common Stock	3518	Indirect
Common Stock	3518	Indirect
Common Stock	3518	Indirect
Common Stock	3518	Indirect
Common Stock	40665	Indirect

Footnotes

F1: The reporting person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Managers of such entities. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

F2: The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

F3: The reporting person is an affiliate of Clajer Capital LLC. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.